Early Access Program

Molecular Sensing is offering a fee-based, technology Early Access Program to facilitate applications development with researchers interested in conducting molecular interaction feasibility studies using BSI technology in academic, pharmaceutical, clinical and commercial diagnostic, and biodefense laboratories.

The R&D team at Molecular Sensing is particularly interested in collaborating with leading research organizations to develop breakthrough applications and assays that will result in significant scientific impact with strong commercialization and revenue generating potential.

Molecular Sensing is actively seeking collaborators to participate in application development initiatives. An overview of the Early Access Program collaboration is described below.

Collaborator receives from Molecular Sensing:

  • Early Access Program includes a BSI instrument, consumables, and support to develop feasibility studies for a fee paid by collaborator.
  • Early Access Program fee includes:
    • BSI instrumentation and consumables.
    • Early access for 12 months to pre-commercialized system upgrades, new consumables, and software enhancements.
    • Expanded training and ongoing technical support.
    • Multiple days of hands-on laboratory feasibility studies in Molecular Sensing's lab in Montara, California.
    • Technical/scientific support for data generation and presentation materials.
Molecular Sensing receives from Collaborator:
  • Validation of novel applications for BSI technology.
  • Feedback on hardware/software/chemistry and workflow.
  • Scientific testimonials in the form of scientific papers, posters, presentations, media interviews, press releases, etc.
  • Financial support.

Targeted Applications

BSI technology has significant applications potential in both kinetic measurements, quantitative molecular interaction based biochemical- and cell-based assays for biomarker discovery, as well as research and diagnostic assays.

Initially, the Early Access Program will focus on end-point assays and Kd measurements. Molecular interactions can include biomolecules such as DNA, RNA, proteins, carbohydrates, small drug molecules, and lipids, along with bacteria, viruses, cells and cell lysates. Experiments are conducted in free-solution so little sample or measurement preparation is required nor extensive knowledge of interacting targets. The material requirements are 10-100 microliter sample volumes (injection volume is <2 microliters) and appropriate controls. Feasibility studies are expected to take two-to-five days to complete.

How to Apply

The first step to gain early access to BSI technology involves completing and submitting a feasibility proposal. Molecular Sensing scientists will review the proposals and work with collaborators to define an implementation work plan. Please contact the Early Access Program director for further details at EAP@molsense.com or call 650-728-8110.